ABRAZO CENTRAL CAMPUS — History
CCN 030030 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$108M
Latest Revenue (FY2022)
-8.2%
Revenue CAGR (3yr)
-10.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $129M | $132M | $108M | -18.0% | -8.2% |
| Operating Expenses | $139M | $141M | $120M | -15.0% | -7.3% |
| Operating Margin | -8.3% | -6.7% | -10.6% | -57.5% | +0.0% |
| Net Income | $-11M | $-9M | $-11M | -29.2% | +0.0% |
| Licensed Beds | 161 | 161 | 153 | -5.0% | -2.5% |
| Total Patient Days | 34,457 | 32,810 | 26,829 | -18.2% | -11.8% |
| Medicare Day % | 16% | 14% | 13% | -6.7% | -11.0% |
| Medicaid Day % | 9% | 3% | 2% | -21.5% | -48.1% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -15.8% ($129M → $108M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-8.2%
This Hospital
+7.6%
State Avg
Latest Margin
-10.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $98M | -11.8% |
| FY2024 (proj) | $88M | -12.9% |
| FY2025 (proj) | $78M | -14.1% |